Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Aug 9, 2019, after the close
10-Q filed Aug 9, 2019, 40 days after period end · 0001144204-19-038872
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $276.00K | $217.00K | $214.00K |
| Net Income | -$23.92M | -$12.24M | -$8.28M | -$6.70M |
| EPS Diluted |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.49 |
| -$0.26 |
| -$0.21 |
| -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.